Press release
Early Cancer Detection Market Size to rise at 13.8% CAGR through 2028 | Grail, Exact Sciences, Gaurdant Health, BGI Genomics
Early Cancer Detection Market
The market research report for Early Cancer Detection is expertly written and comprehensively researched on the status of the market. This statistical surveying report provides the most recent industry data and forecasts, allowing you to identify the products and end users driving growth in revenue and benefit. It focuses on the actual promoters and restraints for the major players, as well as the current state of the challenges and future growth prospects. The study also highlights potential business opportunities in the Early Cancer Detection Market and examines how various factors may hinder or facilitate market analysis.
Asia Pacific region is witnessing the growth in market.
Click & Get a Free Sample Report in Minutes: https://exactitudeconsultancy.com/reports/1092/early-cancer-detection-market/#request-a-sample
Growth Drivers
Increasing incidence of cancer-> the incidence of cancer is rising worldwide, and raising survival rates requires early detection. As a consequence, the market for precise and efficient early cancer detection technologies is expanding.
Advancements in technology: Liquid biopsy, next-generation sequencing, and artificial intelligence (AI) are three recent technological advances that are advancing the creation of new and improved early cancer detection instruments. The detection of cancer biomarkers in blood, urine, and other bodily fluids can now be done more precisely and sensitively thanks to these tools.
Key Companies Profiled in Global Early Cancer Detection Market
Some of the major players of the Early Cancer Detection Market are Grail (Illumina) LLC., Exact Sciences, Gaurdant Health, BGI Genomics, Epigenomics AG, Genetron Health, Berry Genomics, New Horizon Health, and Others.
This report includes changes in customer requirements, customer preferences, and the vendor landscape in the industry with key factors that are expected to influence the overall dynamics of the Early Cancer Detection Market including the current trends, growth opportunities, restraints, and market drivers.
Recent Developments
Grail, a company developing blood tests for early cancer detection, has announced plans to go public through a merger with a special purpose acquisition company (SPAC). The deal values Grail at $8 billion and is expected to provide funding for the company's continued development and commercialization efforts.
Freenome, another company focused on early cancer detection through blood tests, has announced the completion of a $270 million funding round. The company plans to use the funds to advance its technology and expand its clinical trials.
Key Segments Covered in Early Cancer Detection Industry Report
Early Cancer Detection Market By Type, 2023-2028, (IN USD Million)
CTC
CtDNA
Exosomes
Blood Proteomics
Others
Early Cancer Detection Market By Application, 2023-2028, (IN USD Million)
Hospitals
Diagnostic Laboratories
Clinics
Others
Major Points from Table of Contents
Global Early Cancer Detection Market Research Report 2023, through Manufacturers, Regions, Types and Applications
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment through Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East and Africa)
1.4 Years Considered for the Study (2023-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Early Cancer Detection Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments with inside the Early Cancer Detection Market
3.5 Industry News through Region
3.6 Regulatory Scenario through Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Early Cancer Detection Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (through Manufacturing Base, through Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (through Region)
5 Global Early Cancer Detection Market-Segmentation through Type
6 Global Early Cancer Detection Market-Segmentation through Application
7 Global Early Cancer Detection Market-Segmentation through Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence Company Profiles
9 Global Early Cancer Detection Market-Segmentation through Geography
10 Future Forecast of the Global Early Cancer Detection Market from 2023-2028
10.1 Future Forecast of the Global Early Cancer Detection Market from 2023-2028 Segment through Region
10.2 Global Early Cancer Detection Production and Growth Rate Forecast through Type (2023-2028)
10.3 Global Early Cancer Detection Consumption and Growth Rate Forecast through Application (2023-2028)
11 Appendix
11.1 Methodology
12 Research Data Source
Continued....
By Region segment of the Global Early Cancer Detection Market is sub-segmented into:
North America
The U.S.
Canada
Europe
The UK
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
South Korea
Rest of Asia Pacific
Latin America, Middle East & Africa (LAMEA)
Latin America
MEA
This study on post-pandemic business planning will help clients to:
Adjust their strategic planning to move ahead once business stability kicks in.
Build resilience by selecting wisely for individual business divisions, product and service lines when it comes to resources and investments.
Conceptualize scenario-based planning to mitigate future crisis situations.
To learn more about this report, request a free sample copy-> https://exactitudeconsultancy.com/reports/1092/early-cancer-detection-market/#request-a-sample
Customizing reports
Can I change the scope of the report as needed?
yes. Multi-dimensional, deep-level, high-quality modified requirements help customers to accurately grasp market opportunities, effortlessly respond to market challenges, formulate market strategies correctly, act timely, Provide plenty of time and space for competition.
About Us
Exactitude Consultancy is a Market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you. So, whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.
Connect Us:
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS:sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Early Cancer Detection Market Size to rise at 13.8% CAGR through 2028 | Grail, Exact Sciences, Gaurdant Health, BGI Genomics here
News-ID: 2967336 • Views: …
More Releases from Exactitude Consultancy
Huntington's Disease Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Huntington's Disease (HD) is a devastating rare, inherited neurodegenerative disorder that progressively impairs movement, cognition, and behavior. Affecting approximately 3 to 7 individuals per 100,000 globally, it continues to challenge patients, caregivers, and healthcare systems. Despite being rare, the growing investment in research, clinical trials, and novel treatment approaches is transforming the Huntington's Disease market into a promising frontier for biopharmaceutical innovation.
The global Huntington's Disease market is poised for strong…
Hemophilia B Market Emerging Trends and Growth Prospects 2034
Introduction
Hemophilia B is a rare, inherited bleeding disorder caused by a deficiency or dysfunction of clotting factor IX (FIX). Patients with Hemophilia B experience prolonged bleeding episodes, spontaneous internal hemorrhages, and joint damage, which can significantly impair quality of life. The disease predominantly affects males, with an estimated 1 in 25,000 male births worldwide.
For decades, the mainstay of treatment has been factor IX replacement therapy, delivered intravenously. However, repeated infusions,…
Lupus Nephritis Patient Pool Analysis Market is expected to reach USD 15.2 billi …
Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE), an autoimmune disease where the immune system attacks the body's own tissues. LN affects the kidneys, causing inflammation that can lead to organ damage and, if left untreated, kidney failure. With SLE most commonly affecting women of childbearing age, lupus nephritis represents a significant clinical and socioeconomic burden worldwide.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71619
The…
Facioscapulohumeral Muscular Dystrophy (FSHD) Market Massive Growth opportunity …
Introduction
Facioscapulohumeral muscular dystrophy (FSHD) is a rare genetic muscle disorder characterized by progressive weakness of facial, shoulder, and upper arm muscles, and eventually lower body muscles. It is the third most common type of muscular dystrophy, affecting approximately 1 in 8,000 to 1 in 20,000 individuals worldwide.
FSHD is typically caused by abnormal expression of the DUX4 gene due to genetic mutations on chromosome 4. While there is currently no approved…
More Releases for Early
Multi-Cancer Early Detection Market Trends Reflect Strategic Collaborations and …
The Multi Cancer Early Detection Market Size is valued at 1.20 Billion in 2024 and is predicted to reach 5.60 Billion by the year 2034 at a 16.8% CAGR during the forecast period for 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1408
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global multi-cancer early detection market are:
• Increasing prevalence of cancer diseases
• Increasing healthcare expenditure and growing…
Early Warning Radars Market Size Analysis by Application, Type, and Region: Fore …
According to Market Research Intellect, the global Early Warning Radars market under the Aerospace and Defense category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The early warning radars market is witnessing strong expansion driven by heightened global defense modernization efforts and the…
Porchlio now granting early access
**FOR IMMEDIATE RELEASE**
Porchlio Announces Exclusive Early Access to Its Innovative Property Management Software**
In a significant development for property management professionals, Porchlio has opened the doors to early access of its state-of-the-art property management software, specifically designed for managers handling multiple rentals. This groundbreaking platform is poised to revolutionize the industry by streamlining operations through comprehensive rent collection, accounting, maintenance request management, and tenant application, lease, and screening processes.
Understanding the complexity…
Early Cancer Screening Tests Market Overview By Recent Opportunities, Growth Siz …
Global Early Cancer Screening Tests Market Research Report Forcast 2022-2029 provides a key analysis of the market status of the Early Cancer Screening Tests with the best facts and figures, meaning, definition, SWOT analysis, expert opinions, and the latest developments across the globe. The report also calculates the market size, Sales, Price, Revenue, Gross Margin, Market Share, cost structure, and growth rate. The report considers the revenue generated…
Early Toxicity Testing Market is Driven by Rise in Focus on Early Detection of T …
Early Toxicity Testing Market: Introduction
An early toxicity testing or screening is the process of safety assessment which determines the level of tissue or cell damage and maximum safe concentration of any chemical or drug. It is generally performed during preclinical development of products.
Toxicology testing may also be carried out to determine the approximate amount and type of drugs present in the blood such as alcohol, amphetamine, barbiturates, benzodiazepine.
Read Report Overview…
"Early Elton", Tribute Concert
Bill Miles, Summer Breeze Music Project will be performing a music tribute to the early works of Elton John and Bernie Taupin, Sunday, June 6, 2021 at 4pm AZ time on Facebook. Bill is calling this tribute "Early Elton" because it consists of the lyrics by Bernie and the music by Elton created between 1970 to 1975. Please join us for this fun event. https://www.facebook.com/SummerBreezeMusicProject/live_videos/
Song List (10…
